GO
Loading...

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Wednesday, 4 Mar 2015 | 6:17 PM ET

    Baxter International Inc. fell$. 17 or. 2 percent, to $69.25. Bristol-Myers Squibb Co. rose $3.75 or 6.1 percent, to $65.67. Eli Lilly& Co. rose$. 28 or. 4 percent, to $70.65.

  • March 4- Vanda Pharmaceuticals Inc said its experimental atopic dermatitis drug failed a mid-stage study to treat chronic itching. It affects between 9 and 30 percent of the U.S. population, according to the National Institutes of Health. The company regained the U.S. and Canada rights for its schizophrenia drug Fanapt from Novartis AG late last year.

  • Midday Glance: Pharmaceuticals companies Wednesday, 4 Mar 2015 | 1:16 PM ET

    Baxter International Inc. rose$. 11 or. 2 percent, to $69.53. Bristol-Myers Squibb Co. rose$. 86 or 1.4 percent, to $62.78. Eli Lilly& Co. rose$. 16 or. 2 percent, to $70.53.

  • Early Glance: Pharmaceuticals companies Wednesday, 4 Mar 2015 | 10:36 AM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $69.14. Bristol-Myers Squibb Co. fell$. 40 or. 6 percent, to $61.52. Eli Lilly& Co. fell$. 43 or. 6 percent, to $69.94.

  • Final Glance: Pharmaceuticals companies Tuesday, 3 Mar 2015 | 6:05 PM ET

    Baxter International Inc. fell$. 54 or. 8 percent, to $69.42. Bristol-Myers Squibb Co. fell$. 38 or. 6 percent, to $61.92. Eli Lilly& Co. fell$. 75 or 1.1 percent, to $70.37.

  • The number of men being prescribed testosterone jumped more than 75 percent, to 2.3 million, between 2009 and 2013. About 70 percent of these patients were between the ages of 40 and 64, the FDA said. AbbVie Inc's AndroGel, one of the most widely-used products, raked in sales of $934 million in 2014. Other products include Endo International Plc's Testim and Eli...

  • FDA warning: men's testosterone drugs overused Tuesday, 3 Mar 2015 | 12:10 PM ET

    Additionally, the FDA cautioned that the drugs may increase the risk of heart attack, stroke and other cardiovascular problems. Drugmakers must add information about that potential risk to their prescribing labels and conduct a long-term study to further examine the issue, the FDA said. The FDA action follows years of industry marketing for new gels, patches...

  • Final Glance: Pharmaceuticals companies Monday, 2 Mar 2015 | 6:08 PM ET

    Baxter International Inc. rose$. 81 or 1.2 percent, to $69.96. Bristol-Myers Squibb Co. rose $1.38 or 2.3 percent, to $62.30. Eli Lilly& Co. rose$. 95 or 1.4 percent, to $71.12.

  • Early Glance: Pharmaceuticals companies Monday, 2 Mar 2015 | 11:16 AM ET

    Baxter International Inc. rose$. 34 or. 5 percent, to $69.49. Bristol-Myers Squibb Co. rose$. 81 or 1.3 percent, to $61.73. Eli Lilly& Co. rose$. 78 or 1.1 percent, to $70.95.

  • LONDON, March 2- GlaxoSmithKline and Novartis said on Monday they had completed a series of asset swaps worth more than $20 billion that will reshape both drugmakers. GSK is forming a consumer health joint venture with Novartis, while at the same time buying the Swiss company's vaccines business and divesting its cancer drugs portfolio to Novartis.

  • Final Glance: Pharmaceuticals companies Friday, 27 Feb 2015 | 6:02 PM ET

    Baxter International Inc. rose$. 48 or. 7 percent, to $69.15. Bristol-Myers Squibb Co. fell$. 54 or. 9 percent, to $60.92. Eli Lilly& Co. rose$. 14 or. 2 percent, to $70.17.

  • Midday Glance: Pharmaceuticals companies Friday, 27 Feb 2015 | 1:26 PM ET

    Baxter International Inc. rose$. 69 or 1.0 percent, to $69.36. Bristol-Myers Squibb Co. fell$. 26 or. 4 percent, to $61.20. Eli Lilly& Co. rose$. 32 or. 5 percent, to $70.35.

  • Early Glance: Pharmaceuticals companies Friday, 27 Feb 2015 | 11:10 AM ET

    Baxter International Inc. rose$. 33 or. 5 percent, to $69.00. Eli Lilly& Co. fell$. 03 or percent, to $70.00. Hospira fell$. 03 or percent, to $87.51.

  • Final Glance: Pharmaceuticals companies Thursday, 26 Feb 2015 | 6:02 PM ET

    Baxter International Inc. fell$. 19 or. 3 percent, to $68.67. Bristol-Myers Squibb Co. rose$. 24 or. 4 percent, to $61.46. Eli Lilly& Co. fell$. 33 or. 5 percent, to $70.03.

  • Midday Glance: Pharmaceuticals companies Thursday, 26 Feb 2015 | 1:19 PM ET

    Baxter International Inc. fell$. 03 or percent, to $68.83. Bristol-Myers Squibb Co. rose$. 27 or. 4 percent, to $61.49. Eli Lilly& Co. fell$. 57 or. 8 percent, to $69.79.

  • Early Glance: Pharmaceuticals companies Thursday, 26 Feb 2015 | 10:35 AM ET

    Baxter International Inc. fell$. 11 or. 2 percent, to $68.75. Bristol-Myers Squibb Co. fell$. 42 or. 7 percent, to $60.80. Eli Lilly& Co. fell$. 70 or 1.0 percent, to $69.66.

  • Feb 26- Sanofi's new Toujeo diabetes drug has won U.S. regulatory approval but with wording on its label that analysts say could make marketing difficult. Sanofi shares were 1 percent lower at 88.20 euros by 1029 GMT. Sanofi bought some time with a patent infringement lawsuit filed last year against Eli Lilly and Co to keep a cheaper Lantus generic off the market...

  • Midday Glance: Pharmaceuticals companies Wednesday, 25 Feb 2015 | 1:18 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $68.90. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $61.30. Eli Lilly& Co. fell$. 24 or. 3 percent, to $70.66.

  • Early Glance: Pharmaceuticals companies Wednesday, 25 Feb 2015 | 11:23 AM ET

    Baxter International Inc. fell$. 09 or. 1 percent, to $68.97. Bristol-Myers Squibb Co. fell$. 40 or. 7 percent, to $61.05. Johnson& Johnson fell$. 40 or. 4 percent, to $100.30.

  • Final Glance: Pharmaceuticals companies Tuesday, 24 Feb 2015 | 6:02 PM ET

    Baxter International Inc. rose$. 42 or. 6 percent, to $69.06. Bristol-Myers Squibb Co. rose$. 16 or. 3 percent, to $61.45. Eli Lilly& Co. fell$. 19 or. 3 percent, to $70.90.